AMPLogo

Publications And Resources

Press Release Archive

facebook LinkedIn Twitter

 

3/31/10
The Association for Molecular Pathology Celebrates Ruling in DNA Patent Case

The Association for Molecular Pathology (AMP) applauds US District Judge Robert Sweet's ruling in favor of the plaintiffs in the lawsuit, Association for Molecular Pathology, et al. v. U.S. Patent and Trademark Office, et al. "This is a landmark decision that has the potential to dramatically improve patient access to genetic testing. It is a boon to personalized medicine in the purest sense as nothing is more personal than one's genetic makeup. This judgment removes numerous barriers and impediments to clinical research, testing, and innovation since patented genes cannot be invented around, and has implications for how we evaluate each and every patient's genetic information" said Dr. Karen Mann, AMP President.
>>Download Entire Press Release

 

2/9/10
AMP Applauds SACGHS on Release of Final Report on DNA Patents
The Association for Molecular Pathology (AMP) commends the Secretary's Advisory Committee on Genetics, Health, and Society (SACGHS) for its thoughtful, deliberative exploration into the challenges of gene patents and is hopeful that the Secretary of the Department of Health and Human Services will act swiftly to adopt measures that would protect patients from the harms of gene patents and exclusive licensing practices.
>>Download Entire Press Release

 

1/28/10
AMP Releases Statement on Oversight of Laboratory Tests
The Association for Molecular Pathology releases a position statement on the oversight of laboratory developed tests to foster discussion among stakeholders and meets wit the Food & Drug Administration.
>>Download Entire Press Release

 

11/9/09

MEDIA ALERT: The Association for Molecular Pathology (AMP) invites the media to follow its upcoming 2009 Annual Meeting and Exhibits and learn about the latest advances in clinical molecular diagnostics.
>>Download Entire Press Release

 

10/14/09

Association for Molecular Pathology Commends SACGHS on their DNA Patent Report
The Association for Molecular Pathology (AMP) provided comments at the Secretary's Advisory Committee on Genetics, Health and Society (SACGHS) meeting on Oct. 8. AMP opposes the patenting of all naturally occurring genetic material and has signed on as a lead plaintiff in the ACLU case challenging Myriad Genetics' patents on the BRCA 1 and BRCA 2 genes. AMP thanked SACGHS for studying how both patents and restrictive licensing limit patient access and potentially reduce the quality of tests.

>>Download Entire Press Release

 

6/29/09

Association for Molecular Pathology Outlines Key Principles for Health Care Reform
The Association for Molecular Pathology today announced a set of key principles to guide the organization's public policy advocacy amid current effort in Congress and the Obama administration to reform the nation's health care system. These core principles specifically address the practice of clinical laboratory medicine and the use of molecular-based diagnostic tests.

>>Download Entire Press Release

 

6/12/09
Association for Molecular Pathology Urges Comprehensive Measures to Incorporate Molecular Diagnostic Tests Into Comparative Effectiveness Research
The Association for Molecular Pathology (AMP) today released the text of a comment letter it has provided to the Federal Coordinating Council for Comparative Effectiveness Research (CER) in which AMP sets forth its recommendations for priority areas on which to focus CER activities.
>>Download Entire Press Release

 

6/12/09
Association for Molecular Pathology Comments to the SACGHS
In pubic comments given today before the Secretary of Health and Human Services Advisory Committee on Genetics, Health and Society (SACGHS), the Association for Molecular Pathology (AMP) addressed three areas: Comparative Effectiveness Research (CER), evidence for coverage of genetic and genomic tests, and gene patents.
>>Download Entire Press Release

 

5/21/2009
Association for Molecular Pathology Urges Secretary's Advisory Committee to Give Greater Consideration to the Negative Impact of Gene Patents and Restrictive Licensing Practices on Public Health
AMP Comments on Draft Report on Gene Patents and Licensing by the Secretary's Advisory Committee on Genetics, Health and Society
Washington, DC - May 21, 2009 - The Association for Molecular Pathology today urged the Secretary of Health and Human Services' Advisory Committee on Genetics, Health and Society to more definitively explore the negative impact on public health that derives from gene patents and from exclusive and restrictive licensing practices as part of its draft report, Gene Patents and Licensing and Their Impact on Patient Access to Genetic Tests.
>>Download Entire Press Release

 

5/13/2009
Association for Molecular Pathology Joins the American Civil Liberties Union to Challenge the Constitutionality of Gene Patents
Washington, DC - May 13, 2009 - The Association for Molecular Pathology (AMP) announced
today that it is working with the American Civil Liberties Union (ACLU) and the Public Patent
Foundation to bring a lawsuit charging that patents on two human genes associated with breast and ovarian cancer are unconstitutional and should be invalidated. Individuals with certain mutations long these two genes, known as BRCA1 and BRCA2, are at a significantly higher risk for developing hereditary breast and ovarian cancers.
>>Download Entire Press Release

 

5/5/2009
The Association for Molecular Pathology calls for enhanced communication and collaboration between state and local public health laboratories and molecular pathology laboratories to combat the swine influenza A (H1N1) outbreak
Bethesda, MD - April 30, 2009 -- As the nation faces the ongoing public health challenges of a new circulating strain of influenza, the Association for Molecular Pathology (AMP) encourages close collaboration between molecular diagnostics laboratories, CDC , and public health laboratories to ensure prompt diagnosis and timely surveillance of the outbreak. AMP's members are physicians, doctoral scientists and medical technologists with expertise in developing, validating and providing laboratory tests based on molecular methods. They have the education and training to offer high quality molecular diagnostic testing for influenza and extensive experience providing clinical testing for seasonal influenza…
>>Download Entire Press Release

 

12/1/2008
Association of Molecular Pathology Urges an End to the Practice of Granting Patents on Single Genes and Gene Sequences in the Human Genome and to Exclusive Licenses to Genetic Discoveries
In newly adopted Position Statement, group also calls for stakeholders to develop more innovative models of intellectual property to encourage innovation and improve patient access to improved molecular tests
WASHINGTON, DC - December 1, 2008 - In a statement delivered today before the Secretary of Health and Human Services' Advisory Committee of Genetics, Health and Society (SACGHS), the Association of Molecular Pathology (AMP) urged an end to the practice of granting patents on single genes, sequences of the genome or correlations between genetic variations and biological states. AMP also encouraged groups that currently hold gene patents, including higher educational and research institutions, not to grant exclusive licenses to access these patents...
>>Download Entire Press Release

 

10/27/2008
Association for Molecular Pathology holds 14th Annual Meeting and Exhibits, October 29 - November 2, 2008 in Grapevine, TX
Bethesda, MD - October 27, 2008 - The Association for Molecular Pathology (AMP) 14th Annual Meeting and Exhibits will be held October 29 - November 2, 2008 at the Gaylord Texan Resort and Convention Center in Grapevine, Texas. This meeting will feature three days of plenary sessions and workshops in hematopathology, infectious diseases, inherited genetic diseases, solid tumors, and current technical topics presented by leading scientists and diagnosticians in the field of molecular diagnostics...
>>Download Entire Press Release

 

8/25/2008
Association for Molecular Pathology to Increase Public Policy Advocacy Role
Organization Retains HealthFutures as Government Relations Consultant

BETHESDA, MD - July 1, 2008 -- The Association for Molecular Pathology (AMP) announced today plans to significantly increase its activity and visibility in the federal public policy arena for 2008 and beyond. In response to a range of new issues that will impact the emerging field of molecular diagnostics, and in preparation for a national dialogue on health care reform likely to take place in the next presidential administration, the organization will be more actively engaged with policy makers in Congress and the Executive Branch on legislative, regulatory and policy matters...
>>Download Entire Press Release

 

4/03/2007
Daniel H. Farkas, Ph.D. to Receive 2007 Leadership Award From Association for Molecular Pathology
Grand Rapids, Mich. April 3, 2007 - The Center for Molecular Medicine (CMM) today announced that Executive Director Daniel H. Farkas, Ph.D., has been named the recipient of the 2007 Leadership Award from the Association for Molecular Pathology (AMP).
The AMP was founded in 1995 to provide structure and leadership to the then-emerging field of diagnostic molecular pathology. Since 2005, the organization has honored an AMP member with its Leadership Award, based on that member's accomplishments and notable contributions to the vision and direction of both AMP and the field of diagnostic molecular pathology...
>>Download Entire Press Release

    Bookmark and Share